Robert Hoepner
Impact in
-
- Multiple Sclerosis Research Studies
- Neurology top 5%
- Peripheral Neuropathies and Disorders
- Long-Term Effects of COVID-19
- Autoimmune Neurological Disorders and Treatments
Papers in
-
- Multiple Sclerosis Research Studies 66
- Neurology 24
- Long-Term Effects of COVID-19 10
- Peripheral Neuropathies and Disorders 8
- Co-authors
- Andrew Lung-Tat Chan (67 shared papers)Anke Salmen (59 shared papers)Ralf Gold (25 shared papers)Ingo Kleiter (6 shared papers)Carsten Lukas (10 shared papers)Simon Faissner (10 shared papers)Christoph Daniel Friedli (23 shared papers)Ilya Ayzenberg (2 shared papers)
- Journals
- Therapeutic Advances in Neurological Disorders (14 papers)CNS Neuroscience & Therapeutics (9 papers)Neurology Neuroimmunology & Neuroinflammation (9 papers)European Journal of Neurology (8 papers)Multiple Sclerosis Journal (6 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Robert Hoepner
123 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 103
- Pathology and Forensic Medicine 797
- Neurology 310
- Oncology 372
- Infectious Diseases 172
- Biological Psychiatry 22
Countries citing papers authored by Robert Hoepner
This map shows the geographic impact of Robert Hoepner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hoepner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hoepner more than expected).
Fields of papers citing papers by Robert Hoepner
This network shows the impact of papers produced by Robert Hoepner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hoepner. The network helps show where Robert Hoepner may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Hoepner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 168 | |
| 2 | 2013 | 90 | |
| 3 | 2014 | 82 | |
| 4 | 2020 | 70 | |
| 5 | 2023 | 63 | |
| 6 | 2020 | 60 | |
| 7 | 2023 | 60 | |
| 8 | 2016 | 55 | |
| 9 | 2014 | 53 | |
| 10 | 2016 | 50 | |
| 11 | 2015 | 48 | |
| 12 | 2013 | 48 | |
| 13 | 2019 | 44 | |
| 14 | 2019 | 41 | |
| 15 | 2016 | 36 | |
| 16 | 2024 | 34 | |
| 17 | 2018 | 28 | |
| 18 | 2020 | 25 | |
| 19 | 2016 | 24 | |
| 20 | 2021 | 23 |
About Robert Hoepner
Robert Hoepner is a scholar working on Pathology and Forensic Medicine, Neurology, Oncology, Infectious Diseases and Immunology, having authored 137 papers that have together received 1.8k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (66 papers), Polyomavirus and related diseases (22 papers), Long-Term Effects of COVID-19 (10 papers), Peripheral Neuropathies and Disorders (8 papers), SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (4 papers), Psychosomatic Disorders and Their Treatments (4 papers) and Plant Virus Research Studies (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (797 citations), Neurology (310 citations), Oncology (372 citations), Infectious Diseases (172 citations) and Biological Psychiatry (22 citations). Robert Hoepner has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Andrew Lung-Tat Chan, Anke Salmen, Ralf Gold, Ingo Kleiter, Carsten Lukas, Simon Faissner, Christoph Daniel Friedli, Ilya Ayzenberg, Kerstin Hellwig and Ortwin Adams. Their work appears in journals such as Therapeutic Advances in Neurological Disorders, CNS Neuroscience & Therapeutics, Neurology Neuroimmunology & Neuroinflammation, European Journal of Neurology and Multiple Sclerosis Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.